Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Increasing prevalence and incidence rates of multiple sclerosis in Kuwait.
Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Activation of NOD2/RIPK2 pathway induces mitochondrial injury to oligodendrocyte precursor cells in vitro and CNS demyelination in vivo.
Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.
Unusual Presentation of Unilateral Isolated Probable Lyme Optic Neuritis.
Three Minor Diterpenoids with Three Carbon Skeletons from Euphorbia peplus.
Clinical efficacy of plasmapheresis in patients with neuromyelitis optica spectrum disorder and effects on circulating anti-aquaporin-4 antibody levels.
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Rationale and design of a randomized controlled, clinical trial investigating a comprehensive exercise stimulus for improving mobility disability outcomes in persons with multiple sclerosis.
Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork.
Myeloid cell-based therapies in neurological disorders: How far have we come?
Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma: Should it be termed paraneoplastic?
p(70S6K1) in the TORC1 Pathway is Essential for the Differentiation of Th17 Cells, but Not Th1, Th2, or Treg Cells in Mice.
Rates of Adverse Events and Multiple Sclerosis Relapses Before and After Introduction of a Purported Generic Glatiramer Acetate in mexico: Results from a Large Patient Support Program in Mexico.
Changes in brain atrophy indices in patients with relapsing-remitting multiple sclerosis treated with natalizumab.
Multi-Sectional Views Textural Based SVM for MS Lesion Segmentation in Multi-Channels MRIs.
Multiple sclerosis drug fingolimod receives new safety warnings related to cardiovascular risk.
Efficacy of Fish Oil on Serum of TNF α , IL-1 β , and IL-6 Oxidative Stress Markers in Multiple Sclerosis Treated with Interferon Beta-1b.
Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis.
Exploring Physical Activity in Women with Multiple Sclerosis: Associations with Fear of Falling and Underlying Impairments.
THE CLINICAL SPECTRUM OF MICROCYSTIC MACULAR OEDEMA.
Study of fatigue frequency and its association with sociodemographic and clinical variables in patients with multiple sclerosis.
The First Sphingosine 1-Phosphate Lyase Inhibitors against Multiple Sclerosis: A Successful Drug Discovery Tale.

Pages